skip to main content

SciTech ConnectSciTech Connect

Title: TRIF promotes angiotensin II-induced cross-talk between fibroblasts and macrophages in atrial fibrosis

Aims: Atrial fibroblasts and macrophages have long been thought to participate in atrial fibrillation (AF). However, which specific mediator may regulate the interaction between them remains unclear. Methods and results: We provided the evidence for the involvement of Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF), an important inflammation-related molecule, in the pathophysiology of AF. Patients with AF showed higher levels of angiotensin II (AngII) and TRIF expression and larger number of macrophages infiltration in left atria appendage than individuals with sinus rhythm (SR). In the cell study, AngII induced chemokines expressions in mouse atrial fibroblasts and AngII-stimulated atrial fibroblasts induced the chemotaxis of macrophages, which were reduced by losartan and TRIF siRNA. Meanwhile, AngII-stimulated atrial fibroblasts proliferation was enhanced by macrophages. Conclusions: Our data demonstrated that TRIF may be a crucial factor promoting the interaction between atrial fibroblasts and macrophages, leading to atrial fibrosis. - Highlights: • Compared with SR, AF showed higher TRIF expression in left atrial appendage. • TRIF siRNA reversed macrophage chemotaxis induced by AngII-treated fibroblast. • TRIF siRNA reversed chemokines expressions induced by AngII in fibroblast. • AngII-stimulated atrial fibroblast proliferation was enhanced by macrophage.
Authors:
;  [1] ; ; ; ;  [2] ; ;  [1] ;  [1] ;  [2] ;  [1]
  1. Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai (China)
  2. National Key Laboratory of Medical Immunology, Second Military Medical University, Shanghai (China)
Publication Date:
OSTI Identifier:
22462177
Resource Type:
Journal Article
Resource Relation:
Journal Name: Biochemical and Biophysical Research Communications; Journal Volume: 464; Journal Issue: 1; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; ANGIOTENSIN; ATRIA; FIBROBLASTS; FIBROSIS; INFLAMMATION; MACROPHAGES; MICE; PATIENTS; RADIOPROTECTIVE SUBSTANCES; RECEPTORS; SINUSES